Literature DB >> 17064311

Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?

K Kayasut, A Le Tourneau, B Rio, F Bost-Bezeaud, L Heuberger, J Diebold, J Audouin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17064311     DOI： 10.1111/j.1365-2559.2006.02532.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

1.  Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

Authors:  Li Yu; Meifeng Tu; Jorge Cortes; Zijun Y Xu-Monette; Roberto N Miranda; Jun Zhang; Robert Z Orlowski; Sattva Neelapu; Prajwal C Boddu; Mary A Akosile; Thomas S Uldrick; Robert Yarchoan; L Jeffrey Medeiros; Yong Li; David C Fajgenbaum; Ken H Young
Journal:  Blood       Date:  2017-01-18       Impact factor: 22.113

2.  Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis.

Authors:  Shinsuke Isobe; Naro Ohashi; Naoko Katahashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Yoshihide Fujigaki; Akira Shimizu; Hideo Yasuda
Journal:  CEN Case Rep       Date:  2017-09-22

3.  Castleman's Disease with Cutaneous Involvement Manifestating as Multiple Violaceous Plaques on Entire Body.

Authors:  Hyeon-Young Park; Je-Jung Lee; Jee-Bum Lee; Seong-Jin Kim; Seung-Chul Lee; Young Ho Won; Sook Jung Yun
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

4.  Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab.

Authors:  Tetsuro Aita; Sugihiro Hamaguchi; Yoko Shimotani; Yohei Nakamoto
Journal:  BMJ Case Rep       Date:  2020-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.